Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,748 | -1,044 | -1,160 | -2,033 | -2,027 |
| Depreciation Amortization | 2 | 1 | 17 | 155 | 154 |
| Other Working Capital | 55 | -303 | 1,851 | 914 | -249 |
| Other Operating Activity | 232 | 325 | 298 | 590 | -205 |
| Operating Cash Flow | $-1,460 | $-1,022 | $1,005 | $-374 | $-2,327 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | 3 | -9 | -25 |
| Net Acquisitions | N/A | N/A | N/A | 372 | N/A |
| Other Investing Activity | 0 | 850 | -1,250 | 0 | 0 |
| Investing Cash Flow | $-3 | $847 | $-1,247 | $363 | $-25 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 75 | 275 | 125 | N/A | N/A |
| Debt Repayment | 91 | -23 | -21 | -23 | -24 |
| Common Stock Issued | 1,114 | 220 | N/A | N/A | 1,207 |
| Other Financing Activity | 0 | -106 | 106 | 0 | 0 |
| Financing Cash Flow | $1,280 | $366 | $210 | $-23 | $1,183 |
| Beginning Cash Position | 211 | 19 | 51 | 86 | 1,255 |
| End Cash Position | 28 | 211 | 19 | 51 | 86 |
| Net Cash Flow | $-183 | $192 | $-32 | $-34 | $-1,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,460 | -1,022 | 1,005 | -374 | -2,327 |
| Capital Expenditure | -3 | -3 | -1 | -9 | -25 |
| Free Cash Flow | -1,463 | -1,025 | 1,004 | -383 | -2,352 |